335 related articles for article (PubMed ID: 24534633)
1. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
3. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
4. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
[TBL] [Abstract][Full Text] [Related]
5. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice.
Hong X; Li H; Lin Y; Luo L; Xu W; Kang J; Li J; Huang B; Xu Y; Pan H; Guo S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117062. PubMed ID: 37598768
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
8. A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach.
Petersen CP; Meyer AR; De Salvo C; Choi E; Schlegel C; Petersen A; Engevik AC; Prasad N; Levy SE; Peebles RS; Pizarro TT; Goldenring JR
Gut; 2018 May; 67(5):805-817. PubMed ID: 28196875
[TBL] [Abstract][Full Text] [Related]
9. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
10. Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach.
Meyer AR; Engevik AC; Madorsky T; Belmont E; Stier MT; Norlander AE; Pilkinton MA; McDonnell WJ; Weis JA; Jang B; Mallal SA; Peebles RS; Goldenring JR
Gastroenterology; 2020 Dec; 159(6):2077-2091.e8. PubMed ID: 32891625
[TBL] [Abstract][Full Text] [Related]
11. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
12. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
[TBL] [Abstract][Full Text] [Related]
13. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
16. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Radyk MD; Burclaff J; Willet SG; Mills JC
Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
[TBL] [Abstract][Full Text] [Related]
17. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia.
Osaki LH; Bockerstett KA; Wong CF; Ford EL; Madison BB; DiPaolo RJ; Mills JC
J Pathol; 2019 Apr; 247(4):513-523. PubMed ID: 30511397
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.
Bockerstett KA; Lewis SA; Wolf KJ; Noto CN; Jackson NM; Ford EL; Ahn TH; DiPaolo RJ
Gut; 2020 Jun; 69(6):1027-1038. PubMed ID: 31481545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
